Detouring NSAID into Mitochondria to Induce Apoptosis in Cancer Cells

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Mitochondrial dysfunction is a promising strategy for alternative cancer therapy.
• Non-steroidal anti-inflammatory drugs (NSAIDs) show potential for damaging cancer cell mitochondria.
• Targeting NSAIDs specifically to mitochondria presents a significant challenge.

Purpose of the Study:

• To synthesize and evaluate novel NSAID derivatives for targeted mitochondrial drug delivery.
• To investigate the potential of these derivatives in inducing cancer cell death.

Main Methods:

• Synthesis of Meclofenamic acid and Naproxen derivatives with triphenylphosphonium cations.
• Screening of synthesized compounds in cervical (HeLa), breast (MCF7), and colon (HCT-116) cancer cell lines.
• Assessment of mitochondrial damage, reactive oxygen species (ROS) generation, apoptosis markers, and cell death.

Main Results:

• A Meclofenamic acid derivative (8A3) with an ester linkage to a tri(4-methoxyphenyl) phosphonium cation effectively targeted mitochondria.
• Compound 8A3 induced mitochondrial outer membrane permeabilization (MOMP) and ROS generation in HCT-116 cells.
• 8A3 triggered apoptosis by inhibiting Cox-2, reducing Bcl-2/Bcl-xl, and cleaving Caspase-3/9, leading to significant HCT-116 cell death.

Conclusions:

• A novel mitochondrion-targeted Meclofenamic acid derivative (8A3) was successfully synthesized.
• This derivative demonstrates potential as a chemical biology tool for cancer therapy research.
• The findings highlight the therapeutic potential of NSAID-based mitochondrial targeting in cancer treatment.